Exosomes go to war: INOVIQ’s breast cancer therapy
INOVIQ (ASX:IIQ) has completed the first stage of its program for a therapy targeting breast cancer.
Read MoreINOVIQ (ASX:IIQ) has completed the first stage of its program for a therapy targeting breast cancer.
Read MoreDr Leearne Hinch – CEO – INOVIQ Limited (ASX:IIQ) is developing and commercialising a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.
Read MoreINOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
Read MoreA snapshot of the stocks on the move, featuring Northern Star Resources (ASX:NST), GQG Partners (ASX:GQG), Hazer Group (ASX:HZR), INOVIQ (ASX:IIQ) and HMC Capital (ASX:HMC).
Read MoreINOVIQ (ASX:IIQ) has announced progress in breast cancer diagnostics, completing a pivotal study for its "neuCA15-3" blood test.
Read MoreINOVIQ (ASX:IIQ) has announced a breakthrough in detecting ovarian cancer. There are no current recommended screening methods for asymptomatic women.
Read MoreINOVIQ (ASX:IIQ) has received a $1.018m refund under the Australian Government’s Research & Development Tax Incentive program.
Read MoreINOVIQ (ASX:IIQ) highlighted progress in its diagnostic and therapeutic programs in its quarterly update for the period ending 30 September 2024.
Read MoreA snapshot of the stocks on the move, featuring Reach Resources (ASX:RR1), Nico Resources (ASX:NC1), Global Lithium Resources (ASX:GL1) and INOVIQ (ASX:IIQ).
Read MoreINOVIQ (ASX:IIQ) CEO Dr Leearne Hinch presents at the Beijing Two Zones Investment Promotion Webinar (Australia Roadshow), May 2024.
Read MoreA snapshot of the stocks on the move, featuring Immutep (ASX:IMM), INOVIQ (ASX:IIQ) and Eastern Metals (ASX:EMS).
Read MoreDr Leearne Hinch – CEO – INOVIQ (ASX:IIQ) is developing and commercialising a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.
Read MoreINOVIQ Limited (ASX: IIQ) has announced the appointment of David Williams as a Non-Executive Director and Chairman Elect.
Read MoreA snapshot of the stocks on the move, featuring Empire Energy (ASX:EEG), INOVIQ (ASX:IIQ) and Southern Cross Gold (ASX:SXG).
Read MoreWhen it comes to cancer diagnostics, the ‘tried and trusted’ methods are often not the best ones, but merely the techniques clinicians are familiar with. For the ASX-listed INOVIQ (ASX:IIQ), the field is ripe for disruption and the company is wasting no time progressing its precision diagnostics based on two separate platform technologies – SubB2M and EXO-NET.
Read More10 Jul 2023 – INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent news, including excellent sensitivity and specificity results for the company's SubB2M breast cancer test.
Read MoreShares snapped a consecutive decline over the course of four days, while the banking, real estate, and mining sectors outperformed.
Read MoreBHP Group (ASX:BHP) CEO Mike Henry has cautioned against excessive government intervention in global critical minerals supply chains, emphasising the importance of international cooperation and competition to effectively accelerate the energy transition and combat climate change.
Read MoreA snapshot of the stocks on the move featuring INOVIQ, Forrestania Resources, Lincoln Minerals and Tamboran Resources.
Read More